T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C.
GUCY2C
colorectal cancer
immunodominance
listeria
vaccine
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
01
2022
accepted:
10
02
2022
entrez:
31
3
2022
pubmed:
1
4
2022
medline:
9
4
2022
Statut:
epublish
Résumé
The Gram-positive bacterium
Identifiants
pubmed: 35355987
doi: 10.3389/fimmu.2022.855759
pmc: PMC8959893
doi:
Substances chimiques
Cancer Vaccines
0
Epitopes
0
Immunodominant Epitopes
0
Peptides
0
GUCY2C protein, human
EC 4.6.1.2
Receptors, Enterotoxin
EC 4.6.1.2
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
855759Subventions
Organisme : NIDDK NIH HHS
ID : F30 DK127639
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204481
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206026
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA056036
Pays : United States
Informations de copyright
Copyright © 2022 Flickinger, Singh, Yarman, Carlson, Barton, Waldman and Snook.
Déclaration de conflit d'intérêts
SW is a member of the Board and Chair of the Scientific Advisory Board of, and AS is a consultant for, Targeted Diagnostics & Therapeutics, Inc., which provided research funding that, in part, supported this work and has a license to commercialize inventions related to this work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Sci Transl Med. 2019 Jul 17;11(501):
pubmed: 31316010
PLoS One. 2019 Jan 2;14(1):e0209153
pubmed: 30601871
Eur J Cancer. 2017 Aug;81:116-129
pubmed: 28623775
Cancer Gene Ther. 2011 Jan;18(1):53-62
pubmed: 20725099
Cancer Immunol Immunother. 2007 Jun;56(6):927-38
pubmed: 17131121
Infect Immun. 1999 Jan;67(1):131-9
pubmed: 9864207
Annu Rev Med. 2019 Jan 27;70:409-424
pubmed: 30379596
J Biol Chem. 2006 Apr 14;281(15):10618-25
pubmed: 16473882
J Bacteriol. 2002 Aug;184(15):4177-86
pubmed: 12107135
Scand J Immunol. 2004 Feb;59(2):220-7
pubmed: 14871300
Oncoimmunology. 2014 May 23;3:e28926
pubmed: 25083323
Int J Gynecol Cancer. 2018 May;28(4):764-772
pubmed: 29538258
J Clin Oncol. 2015 Apr 20;33(12):1325-33
pubmed: 25584002
J Immunol. 2019 Feb 15;202(4):1301-1310
pubmed: 30642983
Clin Cancer Res. 2019 Oct 1;25(19):5787-5798
pubmed: 31263030
Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13832-7
pubmed: 15365184
Cell Microbiol. 2020 Apr;22(4):e13175
pubmed: 32185899
Mol Ther. 2004 Sep;10(3):432-46
pubmed: 15336644
J Exp Med. 2012 Sep 24;209(10):1769-79
pubmed: 22987800
Nature. 1990 Aug 2;346(6283):476-80
pubmed: 2198471
Immunity. 2006 Oct;25(4):533-43
pubmed: 17046682
Science. 2001 Oct 26;294(5543):849-52
pubmed: 11679669
Hum Gene Ther Methods. 2016 Dec;27(6):238-250
pubmed: 27903079
J Immunol. 1998 May 1;160(9):4441-8
pubmed: 9574549
J Clin Invest. 2018 Aug 1;128(8):3209-3218
pubmed: 30067248
Cancer Immunol Immunother. 2012 May;61(5):713-23
pubmed: 22057677
Oncotarget. 2014 Oct 15;5(19):9460-71
pubmed: 25294806
J Immunother Cancer. 2019 Apr 23;7(1):104
pubmed: 31010434
J Immunol. 2001 Aug 1;167(3):1274-82
pubmed: 11466343
Nature. 2013 Dec 19;504(7480):441-5
pubmed: 24226767
Immunology. 2003 Oct;110(2):163-9
pubmed: 14511229
Oncoimmunology. 2018 May 7;7(8):e1456603
pubmed: 30221049
J Immunother. 2013 Nov-Dec;36(9):468-76
pubmed: 24145358
Genome Announc. 2017 Dec 7;5(49):
pubmed: 29217792
J Immunother Cancer. 2013 Aug 29;1:15
pubmed: 24829751
J Immunol. 2013 Apr 1;190(7):3399-409
pubmed: 23460738
J Immunol. 2017 May 1;198(9):3507-3514
pubmed: 28341670
J Immunol. 1999 Feb 1;162(3):1749-55
pubmed: 9973438
Scand J Immunol. 1999 Jun;49(6):563-9
pubmed: 10354367
Cell Microbiol. 1999 Nov;1(3):249-57
pubmed: 11207557
Clin Cancer Res. 2020 Jul 15;26(14):3578-3588
pubmed: 32273276
Clin Cancer Res. 2020 Feb 1;26(3):679-689
pubmed: 31645352
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8179-8184
pubmed: 30038013
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
EMBO Rep. 2017 Nov;18(11):1889-1892
pubmed: 29021204
Eur J Immunol. 2014 Jul;44(7):1956-66
pubmed: 24771148
Viruses. 2014 Sep 24;6(9):3563-83
pubmed: 25254384
Sci Rep. 2017 Apr 19;7:46418
pubmed: 28422163
Prostate Cancer Prostatic Dis. 2021 Jul 13;:
pubmed: 34257408
J Immunol. 2017 Nov 1;199(9):3348-3359
pubmed: 28939757
Front Cell Infect Microbiol. 2014 May 12;4:51
pubmed: 24860789
Curr Protoc Microbiol. 2013 Nov 05;31:9B.2.1-9B.2.7
pubmed: 24510292
J Immunol. 2005 Sep 15;175(6):3663-73
pubmed: 16148111
Cancer Immunol Immunother. 2008 Sep;57(9):1301-13
pubmed: 18273616
J Immunol. 2012 Dec 15;189(12):5549-60
pubmed: 23175697
Mol Ther. 2021 Feb 3;29(2):555-570
pubmed: 33038322
JTO Clin Res Rep. 2020 Oct 05;2(2):100103
pubmed: 34589981
J Immunother Cancer. 2020 Aug;8(2):
pubmed: 32819976
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):994-9
pubmed: 16418289
J Natl Cancer Inst. 2008 Jul 2;100(13):950-61
pubmed: 18577748
Vaccines (Basel). 2018 Jul 25;6(3):
pubmed: 30044426
Vaccine. 2008 Sep 26;26(41):5315-20
pubmed: 18680778
Immunotherapy. 2021 May;13(7):561-564
pubmed: 33724866